I was curious about Endocyte and the recent acquisition which appeared to be based primarily on one indication (thought they have others in the pipeline). The SP was $1.39 just over a year ago and is $23 as of yesterday. I also noted that back in 2014, the SP reached $6 and then slowly declined to $1.39 in Sept 2017.

Interesting pattern.